Clinical Trials
6
Active:0
Completed:5
Trial Phases
3 Phases
Phase 1:2
Phase 2:1
Phase 4:3
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (6 trials with phase data)• Click on a phase to view related trials
Phase 4
3 (50.0%)Phase 1
2 (33.3%)Phase 2
1 (16.7%)Open-label, Crossover, Food Effect Study to Evaluate CT-044 in Healthy Human Volunteers
- First Posted Date
- 2020-02-05
- Last Posted Date
- 2020-06-12
- Lead Sponsor
- Lotus Clinical Research, LLC
- Target Recruit Count
- 10
- Registration Number
- NCT04252833
- Locations
- 🇺🇸
Lotus Clinical Resarch,LLC, Pasadena, California, United States
Double-blind, Placebo-control, Study to Evaluate the Safety and Pharmacokinetics of CT-044 HCl, in Healthy Volunteers
- First Posted Date
- 2019-11-25
- Last Posted Date
- 2020-07-23
- Lead Sponsor
- Lotus Clinical Research, LLC
- Target Recruit Count
- 21
- Registration Number
- NCT04175743
- Locations
- 🇺🇸
Lotus Clinical Resarch,LLC, Pasadena, California, United States
A Study to Assess the Analgesic Properties of a Sublingual Wafer Formulation of Ketamine Following Third Molar Extraction
Phase 2
Completed
- Conditions
- Pain
- Interventions
- First Posted Date
- 2014-07-24
- Last Posted Date
- 2014-11-21
- Lead Sponsor
- Lotus Clinical Research, LLC
- Target Recruit Count
- 120
- Registration Number
- NCT02199678
- Locations
- 🇺🇸
Lotus Clinical Research, LLC, Pasadena, California, United States
🇺🇸Prahealthsciences, Salt Lake City, Utah, United States
An Open Label, Prospective Study of the Analgesic Efficacy of Oral Xartemis Compared to Generic Oxycodone/APAP( Acetaminophen) in the Treatment of Moderate to Severe Post Operative Pain.
- First Posted Date
- 2014-04-02
- Last Posted Date
- 2018-04-09
- Lead Sponsor
- Lotus Clinical Research, LLC
- Target Recruit Count
- 114
- Registration Number
- NCT02101476
- Locations
- 🇺🇸
Lotus Clinical Resarch,LLC, Pasadena, California, United States
Methodological Validation of Ibuprofen Verses Placebo for Post Operative Pain After Third Molar Extraction Surgery
- First Posted Date
- 2014-03-26
- Last Posted Date
- 2015-04-08
- Lead Sponsor
- Lotus Clinical Research, LLC
- Target Recruit Count
- 40
- Registration Number
- NCT02096926
- Locations
- 🇺🇸
Lotus Clinical Research, LLC, Pasadena, California, United States
- Prev
- 1
- 2
- Next
News
No news found